Veritas In Silico is a pharmaceutical research company that has developed the ibVIS platform, combining informatics and experimental biology to discover mRNA-targeted small molecule drugs in collaboration with pharmaceutical companies.

Yasuhiko Yurimoto

Veritas In Silico

AI Venture X provides tailored AI-powered solutions designed to transform business operations and enhance customer interactions, specializing in e-commerce, legal, and business intelligence sectors. self-described as empowering businesses with innovative AI solutions.

AI Venture X

MYai Robotics LLC provides AI services focused on improving quality of life and enhancing human performance and productivity. Self-described as offering solutions like AI personal assistants, professional sales agents, and education assistance.

MYai Robotics LLC

株式会社電通イノベーションパートナーズ is a corporate venture capital firm within the Dentsu Group, established to invest in emerging companies both domestically and internationally through various CVC funds.

Metric
Company Name	Veritas In Silico	AI Venture X	MYai Robotics LLC	株式会社電通イノベーションパートナーズ
Symbol
MSH ID	COM:GLOBALBRAINS	COM:AIVENTUREX	COM:MYAIROBOTICS	JP:CO:DENTSU-IP
Market	PRIVATE	PRIVATE	PRIVATE	PRIVATE
Sector	Healthcare & Health Services	Technology	Technology	Financial Services & Finance
Industry	Pharmaceutical Research	Artificial Intelligence	Artificial Intelligence	Venture Capital
Country		GB	US	JP
Stage
Employee Count	101
Website	globalbrains.com	aiventurex.com	myairobotics.com	dentsu-ip.co.jp
LinkedIn		ai-venture-x
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

GLOB

COM:GLOBALBRAINS

Veritas In Silico

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue